SS Innovations International (SSII) Share-based Compensation (2016 - 2026)
SS Innovations International's (SSII) quarterly Share-based Compensation came in at $5.9 million in Q1 2026, up 147.43% year-over-year from $2.4 million in Q1 2025, and up 190.94% quarter-over-quarter from $2.0 million in Q4 2025.
Analysis
SS Innovations International (SSII) Share-based Compensation (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Share-based Compensation across 11 years of filings, most recently posting $5.9 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 147.43% year-over-year to $5.9 million; the TTM figure through Mar 2026 stood at $5.9 million (down 72.64% YoY), while the FY2025 annual figure was $8.1 million, down 50.54% from the prior year.
- Share-based Compensation came in at $5.9 million for Q1 2026 at SS Innovations International, up from $2.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $9.7 million in Q4 2023 to a low of -$724965.0 in Q3 2022.
- Average Share-based Compensation over 5 years is $2.4 million, with a median of $2.0 million recorded in 2025.
- Year-over-year, Share-based Compensation tumbled 288.49% in 2022 and soared 21088.76% in 2023.
- Over 5 years, Share-based Compensation stood at $45736.0 in 2022, then soared by 21088.76% to $9.7 million in 2023, then plunged by 75.87% to $2.3 million in 2024, then decreased by 13.49% to $2.0 million in 2025, then jumped by 190.94% to $5.9 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $5.9 million in Q1 2026, $2.0 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.80 Mn |
| 10 | SS Innovations International | 650.44 Mn | 628.15 Mn | 7.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.89 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Mar 31, 2024 | 7.11 Mn |
| Dec 31, 2023 | 9.69 Mn |
| Sep 30, 2023 | 137,000.00 |
| Jun 30, 2023 | 137,000.00 |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 45,736.00 |
| Sep 30, 2022 | -724,965.00 |
| Jun 30, 2022 | 462,490.00 |
| Mar 31, 2022 | 28,240.00 |
| Dec 31, 2021 | 430,119.00 |
| Sep 30, 2021 | 384,615.00 |
| Jun 30, 2021 | 186,975.00 |